Skip to Content

Neogen Corp NEOG

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

Capital Allocation

PREMIUM

Starting Coverage of Neogen With $47 FVE; Growing Genomics Forms Foundation of Firm's Narrow Moat

Aaron Degagne Equity Analyst

Analyst Note

| Aaron Degagne |

We are launching coverage of food and animal safety company Neogen with a $47 fair value estimate, and narrow-moat and stable moat trend ratings. Though Neogen is a well-run, high-quality firm, we think this opinion is shared by the market and fully priced in, and shares have recently been trading near $80, well above even our bull-case fair value estimate of $58. With shares up 20% over the last year, we think investors are generally too bullish about the firm’s prospects, and we would suggest waiting for a more attractive entry point.

Read Full Analysis

Company Profile

Business Description

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety (57% of sales), Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for global food and feed processing companies. In animal safety (43% of sales), Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Neogen is also a market leader in testing for therapeutic drugs for farm and racing animals. Sales in the United States account for 60% of total revenue, while international markets, including Canada, Europe, Asia, and Latin America, account for the other 40% of sales.

Contact
620 Lesher Place
Lansing, MI, 48912
T +1 517 372-9200
Sector Healthcare
Industry Diagnostics & Research
Most Recent Earnings Nov 30, 2020
Fiscal Year End May 31, 2021
Stock Type Classic Growth
Employees 1,764